Concord Wealth Partners

Position in OGN — Organon & Co.

CIK 1814214 ABINGDON, VA

Position in OGN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$135

+$42 QoQ

Shares Held

-23.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#593

of 626 holders

Holding Since

Jun 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $18,338,750 across 12 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	19,775	$5,022,256
2	LLY	ELI LILLY & Co	3,673	$4,405,506
3	AMGN	Amgen Inc	11,144	$4,035,465
4	ABBV	AbbVie Inc.	7,796	$1,961,785
5	BMY	Bristol Myers Squibb Co	20,943	$1,206,735
6	PFE	Pfizer Inc	47,796	$1,150,927
7	MRK	Merck & Co., Inc.	1,770	$227,445
8	NVS	Novartis AG	1,264	$198,094

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$135	10	-23.1%	Shares	Sole	2026-07-27
2025-12-31	$93	13	0.0%	Shares	Sole	2026-01-29
2025-09-30	$138	13	0.0%	Shares	Sole	2025-11-05
2025-06-30	$125	13	-35.0%	Shares	Sole	2025-07-25
2025-03-31	$297	20	0.0%	Shares	Sole	2025-05-02
2024-12-31	$298	20	-98.1%	Shares	Sole	2025-01-24
2024-09-30	$19,799	1,035	-3.3%	Shares	Sole	2024-10-24
2024-06-30	$22,149	1,070	-0.7%	Shares	Sole	2024-07-31
2024-03-31	$20,266	1,078	-3.1%	Shares	Sole	2024-04-30
2023-12-31	$16,035	1,112	+0.2%	Shares	Sole	2024-04-30
2023-09-30	$19,269	1,110	+918.3%	Shares	Sole	2024-04-30
2023-06-30	$2,268	109	-91.0%	Shares	Sole	2023-08-08
2023-03-31	$28,576	1,215	-5.3%	Shares	Sole	2023-04-26
2022-12-31	$35,834	1,283	-12.5%	Shares	Sole	2023-01-30
2022-06-30	$49,477	1,466	+12.7%	Shares	Sole	2022-08-04
2021-12-31	$39,615	1,301	+2143.1%	Shares	Sole	2022-01-21
2021-09-30	$1,901	58	-26.6%	Shares	Sole	2021-11-09
2021-06-30	$2,390	79	—	Shares	Sole	2021-07-29
No filing history on record for this holder in this stock.